Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromocriptine in familial Alzheimer's disease with PSEN1 mutations
NCT04413344Phase 2Completed
- Sponsor
- Kyoto University
- Start
- Jun 2020
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bromocriptine in Alzheimer's disease (AD), sponsored by Kyoto University. Started Jun 2020; status: completed.
02
Drugs
bromocriptine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04413344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04413344.